Eppendorf said this week that it has licensed patents covering gradient technology for thermal cyclers to Takara Bio.

The licensed patents include US Nos. 6,767,512 and 7,074,367, which cover thermal gradient block technology that Eppendorf uses in its Mastercycler Pro Gradient, Mastercycler Gradient, and Mastercycler EP RealPlex thermal cyclers.

The thermal gradient block technology describes a thermostated block that is in contact with wells containing sample vials and generates different temperatures at different sites of the block.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.